Thursday 10 September 2026

One To Watch

Fujifilm


Want to Update your Company's Profile?


Latest Fujifilm News

Fujifilm opens $500 million UK biologics facility
11 February 2026
Fujifilm throws another billion at North Carolina cell culture facility
12 April 2024
The Pharma Letter M&A roundup — March 2022
1 April 2022
Fujifilm strides confidently into US advanced therapies market
23 March 2022
More Fujifilm news >


Today's issue

US generic and biosimilar meds save $496B in just 1 year
Generics
US generic and biosimilar meds save $496B in just 1 year
10 September 2026
Biotechnology
NICE backs Darzalex-based quadruplet for newly-diagnosed myeloma, J&J's second blood cancer win in a week
10 September 2026
Biotechnology
Tyra Biosciences Phase II SURF302 results support LG IR NMIBC with dabogratinib
10 September 2026
Biotechnology
Evommune's EVO756 misses primary endpoint in atopic dermatitis Phase IIb
10 September 2026
Biotechnology
FDA accepts Roche’s Enspryng sBLA for MOGAD
10 September 2026
Biotechnology
Solstice Oncology launches with $225 million to advance neoadjuvant CTLA-4 antibody
10 September 2026
Biotechnology
Alchemab Therapeutics expands leadership team
10 September 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze